# FDA Inspection 1222946 - Community Blood Center of Greater Kansas City - November 14, 2023

Source: https://www.keypedia.com/records/fda_inspections/community-blood-center-of-greater-kansas-city/f30043e7-6c07-4831-a141-845e94139de0
Source feed: FDA_Inspections

> FDA Inspection 1222946 for Community Blood Center of Greater Kansas City on November 14, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1222946
- Company Name: Community Blood Center of Greater Kansas City
- Inspection Date: 2023-11-14
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1078116 - 2019-01-25](https://www.keypedia.com/records/fda_inspections/community-blood-center-of-greater-kansas-city/adcc446d-b789-4b50-aff3-209b59f8b15d)
- [FDA Inspection 993629 - 2016-10-26](https://www.keypedia.com/records/fda_inspections/community-blood-center-of-greater-kansas-city/b0427ada-e82b-489d-856b-9c6d9399b730)
- [FDA Inspection 913229 - 2015-01-22](https://www.keypedia.com/records/fda_inspections/community-blood-center-of-greater-kansas-city/78a6a437-382c-42f4-a47a-e44a8e71ebb5)
- [FDA Inspection 836097 - 2013-06-12](https://www.keypedia.com/records/fda_inspections/community-blood-center-of-greater-kansas-city/967c1c5a-5552-42b8-bb16-195416bb1f1f)
- [FDA Inspection 712177 - 2011-03-01](https://www.keypedia.com/records/fda_inspections/community-blood-center-of-greater-kansas-city/f55b8105-7de6-48ca-9ccf-6ae3f42d0c88)

Company: https://www.keypedia.com/companies/community-blood-center-of-greater-kansas-city/4d33e60e-b6cc-4682-9e27-143ebe54b381

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d